生物技术与人类-小论文郁静雯715080210003 1:331-362 [11]Cavazzana-Calvo M,Hacein-Bey S,de Saint Basile G,et al.Gene therapy of human severe combined immunodeficiency (SCID)-XI disease.Science,2000,288(5466): 669-672 [12]Pearson S,Jia H,Kandachi K.China approves first gene therapy.Nat Biotechnol, 2004,22(1):3-4 [13]http://www.wiley.co.uk/genmed. [14]Ilarduya C T,Sun Y,Duzgunes N.Gene delivery by lipoplexes and polyplexes.Eur J Pharm Sci,.2010,40(3):159-170 [15]Mao C Q,Du JZ,Sun T M,et al.A biodegradable amphiphilic and cationic triblock copolymer for the delivery of siRNA targeting the acid ceramidase gene for cancer therapy.Biomaterials,2011,32(11):3124-3133. [16]Zhang S B,Zhao B D,Jiang H M,et al.Cationic lipids and polymers mediated vectors for delivery of siRNA.J Controlled Release,2007,123(1):1-10. [17]Giacca M,Zacchigna S.Virus-mediated gene delivery for human gene therapy.J Controlled Release,2012,161(2):377-388 [18]姜传仓，范乐明.腺病毒载体及其在基因治疗研究中的应用.生物化学与生物 物理进展，1996,23(1)：9-12 [19]Liang Y R,Liu Z L,Shuai X T,et al.Delivery of cationic polymer-siRNA nanoparticles for gene therapies in neural regeneration.Biochem Biophys Res Commun,.2012,421(4):690-695 [20]Hsu PD,Lander ES,Zhang F.Development and applications of CRISPR-Cas9 for genome engineering [J].Cell,2014,157(6):1262-1278. [21]Lohr JG,Stojanov P,Carter SL,et al.Widespread genetic hetero-geneity in multiple myeloma:Implications for targeted therapy [J].CancerCell,2014,25(1):91-101.生物技术与人类-小论文 郁静雯 715080210003 7 1: 331-362. [11]Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science, 2000, 288(5466): 669-672. [12]Pearson S, Jia H, Kandachi K. China approves first gene therapy. Nat Biotechnol, 2004, 22(1): 3-4. [13]http://www.wiley.co.uk/genmed. [14]Ilarduya C T, Sun Y, Düzgünes N. Gene delivery by lipoplexes and polyplexes. Eur J Pharm Sci, 2010, 40(3): 159-170. [15]Mao C Q, Du J Z, Sun T M, et al. A biodegradable amphiphilic and cationic triblock copolymer for the delivery of siRNA targeting the acid ceramidase gene for cancer therapy. Biomaterials, 2011, 32(11): 3124-3133. [16]Zhang S B, Zhao B D, Jiang H M, et al. Cationic lipids and polymers mediated vectors for delivery of siRNA. J Controlled Release, 2007, 123(1): 1-10. [17]Giacca M, Zacchigna S. Virus-mediated gene delivery for human gene therapy. J Controlled Release, 2012, 161(2): 377-388. [18]姜传仓, 范乐明. 腺病毒载体及其在基因治疗研究中的应用. 生物化学与生物 物理进展, 1996, 23(1): 9-12. [19]Liang Y R, Liu Z L, Shuai X T, et al. Delivery of cationic polymer-siRNA nanoparticles for gene therapies in neural regeneration. Biochem Biophys Res Commun, 2012, 421(4): 690- 695. [20]Hsu PD，Lander ES，Zhang F. Development and applications of CRISPR-Cas9 for genome engineering [J]. Cell，2014，157(6): 1262 -1278. [21]Lohr JG，Stojanov P，Carter SL，et al. Widespread genetic hetero- geneity in multiple myeloma: Implications for targeted therapy [J]. CancerCell，2014，25(1):91-101